All eyes are on ABcann Medicinals, Inc. as it prepares to go public. The company, which is already growing rapidly, wants to expand its footprint in Canada and take advantage of potential international opportunities.
Cannabis Industry
Washington Times Reports Bipartisan Bill would reclassify Marijuana as Schedule 3 Substance
Saturday, April 8, 2017
Bipartisan legislation proposed in the House on Thursday would make marijuana a Schedule 3 drug, removing cannabis from its current standing as a Schedule 1 substance alongside deadly contraband including ecstasy and heroin.
By reclassifying weed in the same category as anabolic steroids, Congress would “make it easier for ill-patients and scientific and medical researchers to obtain marijuana,” the bill’s authors said in a statement Thursday.
InMed Pharmaceuticals, Inc. (IMLFF) Adds to Its Drug Development Pipeline
A pre-clinical stage biopharmaceutical company, InMed Pharmaceuticals, Inc. (OTCQB: IMLFF) has revealed two additions to its drug development pipeline.
India Globalization Capital, Inc. (NYSE: IGC) Announces Sale of Brilliant Hallmark Stake
India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced the sale of its investment interest in Brilliant Hallmark for a consideration of four million shares of IGC.
India Globalization Capital, Inc. (NYSE: IGC) Files Provisional Patent for Treatment of Eating Disorders Using Cannabis Extracts
India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced its filing of a provisional patent for the treatment of multiple types of eating disorders by a method and combination of cannabis extracts and other compounds.
These 5 Public Companies May See Growth from Advanced Extraction for High Quality CBD Oil
Advancements continue to be made in various CBD extractions as the demand for cannabis extracts continues to climb at a high rate. Cannabidiol (CBD) is one of the most important healing substances, with a strong anti-inflammatory effect and without a psychotropic (narcotic) effect.
Marijuana Leader Canopy Growth (TSX:WEED) Fully Valued
Canaccord Genuity analyst Neil Maruoka thinks Canopy Growth Corp. (TSX:WEED) is the “dominant player” in the Canadian cannabis sector, but says the company’s stock is fully valued at current levels.
India Globalization Capital, Inc. (NYSE: IGC) CEO Featured in Benzinga Article
India Globalization Capital (NYSE: IGC) was recently featured in an article detailing the company’s strategic move to the cannabis industry and future plans for the company. In the past, IGC was a company primarily focused on the beneficiation of iron ore.
Marijuana Leader Canopy Growth (TSX:WEED) Fully Valued
Canaccord Genuity analyst Neil Maruoka thinks Canopy Growth Corp. (TSX:WEED) is the “dominant player” in the Canadian cannabis sector, but says the company’s stock is fully valued at current levels.
Agritek Holdings, Inc. Purchases Licensed Cannabis Cultivation Property In Colorado
Agritek Holdings, Inc. (OTC:AGTK), is completing a land purchase contract on an additional thirty-five acre property located in Pueblo County, Colorado. The property will be owned wholly by Agritek Holdings Inc. and will be managed on behalf of Agritek by licensed cultivator partners.
Alternate Health Corp. (CSE:AHG,OTC:ATEHF) Closes a $5.6M Private Placement
Alternate Health Corp. (CSE:AHG,OTC:ATEHF) announced a non-brokered private placement with gross proceeds of CAD $7,569,055 (USD $5,602,834).
Invictus MD (CSE:IMH,OTC:IVITF) Generates $1.5M in 8 Months
Invictus MD (CSE:IMH, OTC:IVITF) reports that Future Harvest Development Ltd. (of which Invictus MD currently owns 82.5%) has generated $1.578 million in revenue.
SeeThruEquity Issues Update on ChineseInvestors.com (CIIX), Increases Price Target to $3.75
Less than two weeks after making a presentation at the SeeThruEquity Conference in Miami Beach, SeeThruEquity increased its price target for ChineseInvestors.com (OTCQB: CIIX) to $3.75.
Organigram Recall is a Huge Opportunity for Investors
Organigram (TSX.V:OGI, OTCQB:OGRMF) began a voluntary recall of a total of 74 products produced between February 1 and December 16, 2016. These lots tested positive for two pesticides that aren't authorized for use on cannabis plants under the Pest Control Products Act but there are long-term benefits for the recall.
Invictus MD Inc. Aquiring Canadian Companies in Preparation of Canadian Legalization
Invictus MD Strategies Inc. (CSE:IMH,OTC:IVITF) has a flurry of recent developments as the company builds a portfolio of Canadian licensed producers preparing to move into the recreational market.